C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 413/12 (2006.01) A61K 31/4178 (2006.01) A61K 31/4196 (2006.01) A61K 31/422 (2006.01) A61K 31/427 (2006.01) A61K 31/433 (2006.01) C07D 417/12 (2006.01) C07D 417/14 (2006.01)
Patent
CA 2384101
The present invention relates to compounds which inhibit, regulate and/or modulate tyrosine kinase signal transduction, compositions which contain these compounds, and methods of using them to treat tyrosine kinase-dependent diseases and conditions, such as angiogenesis, cancer, tumor growth, atherosclerosis, age related macular degeneration, diabetic retinopathy, inflammatory diseases, and the like in mammals.
La présente invention concerne des composés qui inhibent, régulent et/ou modulent la transduction de signaux de tyrosines kinases, des compositions contenant ces composés, et des procédés destinés à leur utilisation pour le traitement de maladies et de troubles dépendant des tyrosines kinases, tels que l'angiogenèse, le cancer, la croissance tumorale, l'athérosclérose, les dégénérescences maculaires liées à l'âge, la rétinopathie diabétique, les maladies inflammatoires, et les maladies du même type chez les mammifères.
Bilodeau Mark T.
Hartman George D.
Hungate Randall W.
Manley Peter J.
Rodman Leonard
Gowling Lafleur Henderson Llp
Merck & Co. Inc.
LandOfFree
Tyrosine kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tyrosine kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tyrosine kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1384733